EchoGo Pro vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose EchoGo Pro if…
Choose EchoGo Pro if your cardiology department requires an advanced, AI-powered solution for automating stress echocardiography analysis to diagnose coronary artery disease efficiently. This tool is ideal for clinics seeking near-instant, accurate reports and seamless integration with existing PACS and clinical workflows, enhancing diagnostic throughput and precision.
View EchoGo Pro →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if your practice needs a rapid, non-invasive screening tool for early detection of low ejection fraction during routine physical exams. This solution is best suited for clinicians in primary care or general cardiology looking to quickly identify patients at risk for heart failure using an integrated digital stethoscope.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoGo Pro | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Pricing | Contact vendor for pricing | Unknown |
| Deployment | Cloud-based | Unknown |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoGo ProEchoGo Pro (Tool A) emphasizes a SaaS model requiring no software installation or extensive training, along with seamless integration into existing clinical workflows (DICOM, HL7) and vendor-neutral PACS compatibility. This highlights ease of deployment and integration for IT departments and specialists. While ELEFT (Tool B) offers quick results at the point of care, its reliance on specific Eko digital stethoscopes adds a hardware dependency.
Clinical Value
EchoGo ProEchoGo Pro (Tool A) is FDA-cleared and directly improves the diagnostic accuracy of coronary artery disease through automated stress echocardiography analysis, aiming to reduce misdiagnosis. ELEFT (Tool B) aids in the early detection of low ejection fraction, which is valuable for screening, but Tool A's direct impact on the accuracy of a definitive diagnostic test provides a strong, measurable clinical outcome.
Pricing & Value
EchoGo ProBoth tools require contacting the vendor for pricing, indicating a lack of transparency. However, EchoGo Pro (Tool A) explicitly mentions the availability of reimbursement codes for related EchoGo products, which provides a clearer path for healthcare providers to justify the financial investment and achieve sustainability. ELEFT (Tool B) is part of an enterprise platform, which may imply a larger, less flexible pricing structure.
Enterprise Readiness
EchoGo ProBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, essential for enterprise adoption. EchoGo Pro (Tool A) stands out with its explicit mention of being a 'vendor-neutral system, compatible with any PACS' and offering 'seamless integration with existing clinical workflows (DICOM, HL7)'. These features are crucial for integration into diverse and complex healthcare IT environments.
Innovation
Eko Low Ejection Fraction Tool (ELEFT)Eko Low Ejection Fraction Tool (ELEFT) (Tool B) demonstrates greater innovation by integrating an AI algorithm with a common, non-invasive tool like a digital stethoscope for early detection of heart failure risk during routine physical exams. This approach brings advanced screening capabilities to the point of care in a broadly accessible manner, potentially transforming primary care. EchoGo Pro (Tool A) innovates within a specialized imaging domain, enhancing an existing diagnostic process.
Support & Docs
Eko Low Ejection Fraction Tool (ELEFT)While neither tool's structured facts explicitly detail support or documentation, Eko Health (Tool B) provides readily accessible user manuals for its integrated Eko digital stethoscopes on its support website, which is a direct and tangible form of operational documentation for the end-user. Ultromics (Tool A) mentions dedicated customer support and training, but specific documentation resources are less apparent.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoGo Pro | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Name | EchoGo Pro | Eko Low Ejection Fraction Tool (ELEFT) |
| Company | Ultromics | Eko Health |
| Primary Function | Automates stress echocardiography analysis to improve the diagnosis of coronary artery disease. | Aids clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. |
| Key Integration/Hardware | Vendor-neutral system, compatible with any PACS; seamless integration with DICOM, HL7. | Integrates with FDA-cleared Eko digital stethoscopes. |
| Result Speed | Near-instant reports | Approximately 15 seconds |
| Target Condition | Coronary Artery Disease (CAD) | Low ejection fraction (indicator of heart failure) |
Videos
Demos, reviews, and walkthroughs featuring EchoGo Pro and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring EchoGo Pro or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.